Leidos Holdings stock holds in the mid-$140s as Q2 2026 beat and guidance hike frame the outlook
Published on 08/20/2026 at 13:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Leidos Holdings Inc. (US5253271028) stock is trading in the mid-$140s in August 2026, with the latest quotes showing the shares around $146 as investors weigh a strong second-quarter 2026 earnings beat against a pullback from earlier highs.
Stock price and recent move
Per one real-time market-data overview as of August 19, 2026, Leidos Holdings closed at $146.29, marking a gain of 1.96% for that session and reflecting renewed buying interest after earlier volatility. That same quote snapshot reported a market capitalization of $18.36 billion for Leidos, underlining the company’s scale in the U.S. defense and technology services space.
A separate price comparison tool citing data for August 20, 2026 showed Leidos at $146.31 versus a peer at $125.95, indicating that Leidos shares trade at a higher absolute level than at least one listed competitor in the government-services segment. The same comparison highlighted Leidos near the $146 mark while still below the recent 52-week ceiling near $159 reported by another market portal, suggesting room for recovery if earnings momentum holds.
Earlier quotes compiled by a stock-news portal pointed to a closing price of $146.34 on August 19, 2026, followed by extended-hours trading slightly below that level, which fits with the intraday gain around 2% reported by multiple market snapshots for that date. The same news page framed this move in the context of investor reaction to recent earnings and guidance.
Q2 2026 earnings beat
The current trading range sits against the backdrop of robust second-quarter 2026 results that were released earlier in August and continue to shape sentiment in late August 2026. A detailed earnings overview summarizing the quarter reported revenue of $4.6 billion in Q2 2026, an increase of 7% year over year compared with the prior-year quarter. The same overview noted that Wall Street had expected around $4.4 billion in revenue, meaning Leidos outperformed consensus by $0.2 billion in the quarter.
On the bottom line, adjusted diluted earnings per share for Q2 2026 came in at $3.26, above the consensus expectation of $2.90 cited in the same analyst-focused article, implying an earnings beat of $0.36 per share. The overview also indicated that Leidos has beaten consensus earnings estimates in each of the last four quarters, building a track record of upside surprises that can support valuation when markets reassess the stock after results.
Another Q2 2026 synopsis for Leidos reported net income of $356 million for the quarter, translating into $2.81 per diluted share under GAAP, alongside adjusted EBITDA of $631 million and an adjusted EBITDA margin of 13.8%. That same summary highlighted cash flows from operations of $793 million and non-GAAP free cash flow of $761 million in the quarter, underscoring that earnings quality was backed by strong cash generation.
The Q2 2026 period also saw substantial contract activity. According to the same financial summary, Leidos secured $5 billion in contract awards across defense, intelligence and healthcare work, including hypersonic missile tracking payloads and AI-powered ISR support assignments. These awards not only contribute to the current backlog but also support the company’s positioning in advanced defense technology and data-driven services, which investors may view as key growth engines over the next few years.
Guidance raised and fiscal 2025 context
Following the Q2 2026 beat, Leidos raised its full-year 2026 guidance in early August, and those updated targets remain an important anchor for the stock’s valuation in late August 2026. The guidance now calls for full-year 2026 revenue between $18.2 billion and $18.4 billion, narrowing the outlook around a mid-point of $18.3 billion and implying mid-single-digit growth versus the preceding year. The same guidance document also sets a full-year range for non-GAAP diluted EPS of $12.20 to $12.50, compared with prior consensus figures around $12.38 cited in the analyst overview.
Analyst expectations for the fiscal year ending in December 2026 now envisage diluted EPS growth of 3.3% to reach around $12.38, which sits near the mid-point of the company’s own non-GAAP guidance range. This alignment between company guidance and the external consensus reinforces the narrative that Leidos is on a stable earnings-growth trajectory, rather than delivering only one-off upside surprises.
For additional context, a recent multi-year profile of Leidos noted that annual revenues for the fiscal year ended January 2, 2026 were around $17.2 billion, providing a base from which the newly guided $18.2 billion to $18.4 billion revenue range would represent growth of roughly $1.0 billion to $1.2 billion year over year. The same profile pointed out that analysts project revenue reaching $20.3 billion by 2029, which would require annual growth of 5.4% from current levels, suggesting that the 2026 guidance is broadly consistent with longer-term expectations.
Analyst view and price targets
Beyond the company’s own guidance, the current analyst stance and price targets give investors a sense of how much upside the market community sees in Leidos Holdings stock relative to its mid-$140s trading level. An earnings-focused article summarizing the latest ratings indicated that among 18 analysts covering the stock, the consensus rating stands at a moderate buy, with seven strong buy recommendations, one moderate buy rating and 10 holds. This mix reflects a constructive but not euphoric stance, with a significant share of analysts seeing upside but many also recommending patience.
The same article highlighted a mean price target of $160.12 for Leidos, representing a premium of 11.6% to the current price level used in that analysis. With the shares trading around $146 in late August 2026, that average target still points to double-digit percentage upside if Leidos continues to execute against its guidance and contract pipeline. A street-high target of $225 was also cited, implying potential upside of 56.8% from the reference price in the article, although such high targets generally reflect more aggressive assumptions on growth, margins or valuation multiples than the broader analyst set.
One prominent analyst call described in the same piece involved a price-target increase to $165 with an equal-weight rating, implying potential upside of 15% from the reference price level in that call. Taken together with the mean target of $160.12, these numbers show that while the consensus is not unanimously bullish, several major research houses regard the current valuation as leaving meaningful room for appreciation if Leidos hits its earnings and revenue targets into 2027.
Another secondary source that focuses directly on whether analysts are bullish on Leidos Holdings stock reiterated the mean target of $160.12 and emphasized that this figure sits comfortably above the current market price in the mid-$140s. That discussion underscores the extent to which Leidos is viewed as a steady compounder rather than a speculative high-growth story, with valuation support anchored in recurring government contracts.
AI and advanced defense capabilities
For many investors, the appeal of Leidos lies not only in its steady contract flow but also in its evolving role in artificial intelligence and advanced defense technology. A recent thematic analysis of Leidos’ AI initiatives pointed to an internal program branded AI Fight Club, which provides a simulated environment for testing AI systems across air, land, sea and space. The same analysis highlighted that current efforts focus on using AI to help warfighters process complex information and make faster decisions on the battlefield.
This AI work dovetails with the Q2 2026 contract awards in hypersonic missile tracking and ISR support, where AI-driven processing and sensor fusion can meaningfully differentiate Leidos’ offerings from more traditional systems integration work. Sector commentary has also noted that, on certain valuation metrics, Leidos trades at a discount to broader technology multiples, with a forward 12-month price-to-sales ratio under 1x compared with double-digit multiples for some higher-growth AI names, which may appeal to investors seeking exposure to defense-focused AI at a more modest valuation.
The same AI-focused commentary indicated that consensus earnings estimates for 2026 have been revised higher over the prior 60 days as analysts incorporate the Q2 2026 beat and the raised guidance into their models. Against that backdrop, the stock currently carries a hold-equivalent rating in that outlet’s framework, which is consistent with the broader moderate buy consensus, suggesting that the market is still looking for further proof points on long-term AI monetization before assigning premium multiples.
Representative product and business segment
Within its broad portfolio, one representative area that showcases Leidos’ capabilities is its work on hypersonic missile tracking payloads, as highlighted in the Q2 2026 contract summary. These payloads are designed to help detect and track ultra-fast projectiles that travel at speeds making them difficult to monitor using conventional radar systems. By combining advanced sensors with AI-enabled data processing, Leidos aims to offer defense customers better visibility into emerging threats and to improve response times.
Operationally, this type of program illustrates how Leidos blends hardware, software and systems engineering in contracts that can span several years and generate recurring revenue as upgrades, maintenance and associated services continue after the initial deployment. For retail investors, such contracts are a tangible example of the company’s role in critical national-security infrastructure, which can provide a relatively resilient revenue base compared with more cyclical commercial technology spending.
Stock positioning and closing price context
Leidos Holdings stock is listed on the NYSE under the ticker LDOS, and recent quote pages show the shares trading around $146 in U.S. dollars in mid-August 2026. As of the completed session on August 19, 2026, one market snapshot recorded a closing price of $146.29 at 4:00 p.m. ET, providing the most recent full-session benchmark for the stock in the lead-up to August 20, 2026. With a market capitalization of $18.36 billion attached to that quote, Leidos remains a sizable constituent within the U.S. defense and technology services universe.
For investors, the key narrative at this stage is that a solid Q2 2026 beat, raised full-year revenue and EPS guidance, and supportive but measured analyst targets collectively underpin the stock in the mid-$140s, even as the shares trade below the 52-week high near $159 reported by market portals. How quickly Leidos can convert its $5 billion in recent contract awards and its AI initiatives into sustained margin expansion will likely determine whether the stock moves closer to the $160 mean target or remains range-bound around current levels.
Read more
More detailed information on Leidos Holdings’ strategy, contract portfolio and investor communications can be found on the company’s own website under its investor relations and news sections. Retail investors who want to go deeper into segment performance and backlog trends may also review recent earnings presentation materials and conference-call transcripts hosted there.
Leidos technology services
Beyond headline contracts, Leidos offers a wide range of technology services across defense, intelligence, civil and healthcare markets. Solutions include systems integration, cybersecurity, enterprise IT modernization and mission-focused analytics. These services are often delivered under multi-year framework agreements with U.S. federal agencies and allied governments, providing recurring revenue streams that complement more project-based defense programs.
The company’s healthcare technology offerings, for instance, encompass electronic health record support and data-analytics solutions that help large providers manage patient flows and clinical information. On the civil side, Leidos is active in energy grid modernization and transportation systems, where digitalization and resilience have become key priorities for public-sector customers. These varied segments help diversify Leidos’ revenue base, reducing dependence on any single end market while still keeping the core focus on mission-critical services.
Latest price snapshot
As of the completed regular trading session on August 19, 2026, the most recent full-session quote from a real-time portal showed Leidos Holdings (LDOS) closing at $146.29 in New York, with that price serving as the reference level for market cap calculations of $18.36 billion at that time. Investors tracking Leidos’ performance in August 2026 therefore see a stock that has rebounded from earlier levels closer to $143 while still trading below recent highs near $159, leaving a gap that could close if upcoming quarters match or exceed the current guidance trajectory.
Fact box
Company: Leidos Holdings Inc.
ISIN: US5253271028
Ticker: LDOS
Exchange: NYSE
Price (as of August 19, 2026, 4:00 p.m. ET): $146.29 USD
Market cap: $18.36 billion (as of August 19, 2026)
Sector / Industry: Industrials / Aerospace and defense services
Index membership: S&P 500
